Article: "MIV Therapeutics (OTCBB:MIVT)" completes strategic acquisition of "BioSync Scientific"; aims to become world leader in $8B industry...

M2 PRESSWIRE-19 February 2007-Business to Leisure Monthly: "MIV Therapeutics (OTCBB:MIVT)" completes strategic acquisition of "BioSync Scientific"; aims to become world leader in $8B industry...(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:19022007

BTLMonthly.com has a Monthly Magazine, a Mid-Month Edition, and a Daily News Bulletin that features undervalued companies poised for growth. BTLMonthly.com features the Top Reasons to watch said companies.

Top 7 Reasons to Watch MIV Therapeutics, Inc. (OTCBB:MIVT):

1. HUGE MARKET - the total cardiovascular stent market in 2005 was approximately $7 billion in 2005.

2. PRODUCT RECOGNITION ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!